Skip to content
10-K

Annual Report

SANGUI BIOTECH INTERNATIONAL INC

0001096906-22-002384

← back to feed
Filed
Sep 28, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Sep 28, 2022 209.9M sh
Operating Cash Flow FY 2022 · Jun 30, 2022 −$140.46K
Operating Cash Flow FY 2022 · Jun 30, 2021 −$145.85K
Short Term Debt FY 2022 · Jun 30, 2022 $707.7K
Short Term Debt FY 2022 · Jun 30, 2021 $752.51K
Cash And Equivalents FY 2022 · Jun 30, 2022 $30.47K
Cash And Equivalents FY 2022 · Jun 30, 2021 $29.77K
Stockholders Equity FY 2022 · Jun 30, 2022 −$239.13K
Stockholders Equity FY 2022 · Jun 30, 2021 −$223.53K
Current Liabilities FY 2022 · Jun 30, 2022 $935.62K
Current Liabilities FY 2022 · Jun 30, 2021 $954.71K
Total Liabilities FY 2022 · Jun 30, 2022 $1.03M
Total Liabilities FY 2022 · Jun 30, 2021 $1.01M
Current Assets FY 2022 · Jun 30, 2022 $67.71K
Current Assets FY 2022 · Jun 30, 2021 $66.67K
Total Assets FY 2022 · Jun 30, 2022 $130.79K
Total Assets FY 2022 · Jun 30, 2021 $134.12K
Sga Expense FY 2022 · Jun 30, 2022 $53.21K
Sga Expense FY 2022 · Jun 30, 2021 $48.68K
Rd Expense FY 2022 · Jun 30, 2022 $8.57K
Rd Expense FY 2022 · Jun 30, 2021 $8.27K
Net Income FY 2022 · Jun 30, 2022 −$59.31K
Net Income FY 2022 · Jun 30, 2021 −$198.89K
Operating Income FY 2022 · Jun 30, 2022 −$139.45K
Operating Income FY 2022 · Jun 30, 2021 −$151.14K
Gross Profit FY 2022 · Jun 30, 2022 $69.19K
Gross Profit FY 2022 · Jun 30, 2021 $65.59K
Revenue FY 2022 · Jun 30, 2022 $69.19K
Revenue FY 2022 · Jun 30, 2021 $65.59K